Recent Company News

• 06:44 AM ET Apr 18, 2026
  

  COMPARE study of Sanofi's Nuvaxovid vs Moderna's mNEXSPIKE meets primary endpoint (€82.02, 0.00)

• 04:39 PM ET Apr 17, 2026
  

  Follow-up: Odyssey Therapeutics, Inc. files for Nasdaq IPO of indeterminate amount - S-1

• 06:35 PM ET Apr 10, 2026
  

  Follow-up: Hemab Therapeutics files for Nasdaq IPO of indeterminate size

• 04:16 PM ET Apr 10, 2026
  

  Follow-up: Seaport Therapeutics files for Nasdaq IPO of indeterminate size - S-1

• 08:29 AM ET Apr 09, 2026
  

  Heidelberg Pharma Determines Recommended Dose for Phase II Trial with ADC Candidate HDP-101 (€2.79, 0.00)

• 08:50 AM ET Apr 08, 2026
  

  Takeda Pharmaceutical upgraded to outperform at Bernstein (¥5789.0000, 0)

• 05:17 PM ET Apr 06, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 08:43 AM ET Apr 06, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 11:07 PM ET Apr 01, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (65 total)

• 11:06 PM ET Apr 01, 2026
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (64 total)